Company / Working Capital
ATOSSA THERAPEUTICS, INC. Working Capital History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.8M
FY2016
5-year range
$338.9K / $6.9M
FY2012-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $7M to $2M over the past 2 years.
Based on SEC 10-K filings.
$2M in FY2016 with a 3-year CAGR of -33.2%.
Declined from $7M to $2M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -33.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -33.2%, indicating a declining trend.
- In FY2016, working capital increased 0.0% year-over-year.
- Peak working capital was recorded in FY2014.
- Lowest working capital in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $1.8M | +0.0% |
| FY2015 | $1.8M | -73.9% |
| FY2014 | $6.9M | +14.4% |
| FY2013 | $6.0M | +1672.3% |
| FY2012 | $338.9K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026